CUSIP 482929106COMKLRSQ4 2025
7 filings · latest Feb 17, 2026
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Samsara Biocapital, LLC | 12.95M | $109.28M |
| 2 | Rtw Investments, LP | 1.30M | $10.97M |
| 3 | Paradigm Biocapital Advisors LP | 700.0K | $5.91M |
| 4 | Siren, L.L.C. | 435.8K | $3.68M |
| 5 | Alyeska Investment Group, L.P. | 403.6K | $3.40M |
| 6 | Ikarian Capital, LLC | 360.0K | $3.04M |
| 7 | Vanguard Group Inc | 292.8K | $2.47M |
| 8 | Kalehua Capital Management LLC | 139.9K | $1.18M |
| 9 |
| 4 | Jul 29, 2025 | Invus Public Equities, L.P. | 13G/A | 1.5% | 282.6K | SEC |
| 5 | May 15, 2025 | Ecor1 Capital, LLC | 13G/A | 1.1% | — | SEC |
| 6 | Mar 25, 2025 | Samsara Biocapital, L.P. | 13D | 61.2% | — | SEC |
| 7 | Mar 20, 2025 | Gilead Sciences, Inc. | 13G/A | 3.9% | 723.3K | SEC |
| Woodline Partners LP |
| 100.0K |
| $844.0K |
| 10 | Adar1 Capital Management, LLC | 100.0K | $844.0K |